Pfizer Announces New Organizational Structure in China, Establishes Dedicated General Expansion Business Unit for the First Time

On September 24, Pfizer announced a comprehensive restructuring of its organizational framework in China. The new structure comprises six independent business units: Hospital Acute Care, Oncology, Rare Diseases, Inflammation & Immunology, Vaccines, and Broad Market. Among them, the Broad Market team has been established as an independent business unit for the first time.

Source: Health Times